Weak Adoption and Performance of Hepatitis B Birth-Dose Vaccination Programs in Africa: Time to Consider Systems

Tasneem Solomon-Rakiep1,2, Jill Olivier1, Edina Amponsah-Dacosta2

  • 1Health Policy and Systems Division, School of Public Health, Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town 7925, South Africa.

Insights

Hepatitis B virus (HBV) mother-to-child transmission (MTCT) remains high in African children due to missed vaccination opportunities. Improving antenatal care and addressing health system barriers are crucial for effective HBV control.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Health Systems Research

Background:

  • Chronic hepatitis B (CHB) in young African children indicates failures in preventing mother-to-child transmission (MTCT) of the hepatitis B virus (HBV).
  • The co-epidemic of HIV exacerbates the risk of HBV MTCT in Africa.
  • Suboptimal implementation of HBV MTCT mitigation strategies, particularly birth-dose vaccination, persists.

Purpose of the Study:

  • To conduct a scoping review of the evidence on HBV MTCT risks in Africa.
  • To assess the current status of HBV MTCT mitigation strategies, focusing on birth-dose vaccination.
  • To identify health systems barriers affecting the adoption and performance of HBV birth-dose vaccination programs.

Main Methods:

  • A comprehensive scoping review of 88 peer-reviewed and grey literature sources published between 2000 and 2022.
  • Analysis of evidence on HBV MTCT risk, mitigation strategies, and health systems factors.
  • Development of an adapted systems-based logic model to understand program performance.

Main Results:

  • Evidence consistently shows a high risk of HBV MTCT, amplified by the HIV co-epidemic.
  • Selective hepatitis B birth-dose vaccination, without universal HBV screening in antenatal care, is insufficient to interrupt MTCT.
  • Significant health systems barriers impede the universal adoption and optimal performance of HBV birth-dose vaccination programs.

Conclusions:

  • Interrupting HBV MTCT requires integrated universal screening and timely birth-dose vaccination.
  • Addressing complex health systems barriers is essential for effective HBV control programs in Africa.
  • Future research should explore complex systems approaches for scaling up HBV birth-dose vaccination programs regionally.

Related Concept Videos

Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
957
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Vaccinations01:51

Vaccinations

Overview
44.6K